These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17889568)

  • 1. Aging-related changes of QT and RR intervals in conscious guinea pigs.
    Shiotani M; Harada T; Abe J; Hamada Y; Horii I
    J Pharmacol Toxicol Methods; 2008; 57(1):23-9. PubMed ID: 17889568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methodological validation of an existing telemetry system for QT evaluation in conscious guinea pigs.
    Shiotani M; Harada T; Abe J; Hamada Y; Horii I
    J Pharmacol Toxicol Methods; 2007; 55(1):27-34. PubMed ID: 16831559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QT and RR intervals in conscious and anesthetized guinea pigs with highly varying RR intervals and given QTc-lengthening test articles.
    Hamlin RL; Kijtawornrat A; Keene BW; Hamlin DM
    Toxicol Sci; 2003 Dec; 76(2):437-42. PubMed ID: 14600288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of terfenadine and ketoconazole-induced QT prolongation in conscious telemetered guinea pigs.
    Rajput SK; Singh JN; Sharma SS
    Pharmacol Rep; 2010; 62(4):683-8. PubMed ID: 20885008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical application of guinea pig telemetry system for QT evaluation.
    Shiotani M; Harada T; Abe J; Sawada Y; Hashimoto K; Hamada Y; Horii I
    J Toxicol Sci; 2005 Aug; 30(3):239-47. PubMed ID: 16141657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo effects of the IKr agonist NS3623 on cardiac electrophysiology of the guinea pig.
    Hansen RS; Olesen SP; Rønn LC; Grunnet M
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):35-41. PubMed ID: 18594476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calculation of QT shift in non clinical safety pharmacology studies.
    Champeroux P; Martel E; Fowler JS; Maurin A; Sola ML; Jude S; Elamrani F; Weyn AA; Laveissiere A; Lala P; Richard S
    J Pharmacol Toxicol Methods; 2009; 59(2):73-85. PubMed ID: 19135537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurements of blood pressure and electrocardiogram in conscious freely moving guineapigs: a model for screening QT interval prolongation effects.
    Hess P; Rey M; Wanner D; Steiner B; Clozel M
    Lab Anim; 2007 Oct; 41(4):470-80. PubMed ID: 17988441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-dependent effects on cisapride-induced QTc prolongation in the isolated guinea pig heart.
    Mittelstadt SW; Adams NA; Spruell RD
    J Pharmacol Toxicol Methods; 2006; 54(2):159-63. PubMed ID: 16624595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anesthetized guinea pig: an effective early cardiovascular derisking and lead optimization model.
    Morissette P; Nishida M; Trepakova E; Imredy J; Lagrutta A; Chaves A; Hoagland K; Hoe CM; Zrada MM; Travis JJ; Zingaro GJ; Gerenser P; Friedrichs G; Salata JJ
    J Pharmacol Toxicol Methods; 2013; 68(1):137-49. PubMed ID: 23649000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship of clinical QT prolongation to outcome in the conscious dog using a beat-to-beat QT-RR interval assessment.
    Fossa AA; DePasquale MJ; Raunig DL; Avery MJ; Leishman DJ
    J Pharmacol Exp Ther; 2002 Aug; 302(2):828-33. PubMed ID: 12130750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Halothane-anaesthetized, closed-chest, guinea-pig model for assessment of drug-induced QT-interval prolongation.
    Sakaguchi Y; Takahara A; Nakamura Y; Akie Y; Sugiyama A
    Basic Clin Pharmacol Toxicol; 2009 Jan; 104(1):43-8. PubMed ID: 18699795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Problems of heart rate correction in assessment of drug-induced QT interval prolongation.
    Malik M
    J Cardiovasc Electrophysiol; 2001 Apr; 12(4):411-20. PubMed ID: 11332559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related differences of QT interval and autonomic nervous system activity in female cynomolgus monkeys.
    Ishizaka T; Yoshimatsu Y; Ozawa M; Kimotsuki T; Takasaki W; Manabe S; Yasuda M
    J Pharmacol Toxicol Methods; 2009; 60(3):288-95. PubMed ID: 19586616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel predictive pharmacokinetic/pharmacodynamic model of repolarization prolongation derived from the effects of terfenadine, cisapride and E-4031 in the conscious chronic av node--ablated, His bundle-paced dog.
    Nolan ER; Feng MR; Koup JR; Liu J; Turluck D; Zhang Y; Paulissen JB; Olivier NB; Miller T; Bailie MB
    J Pharmacol Toxicol Methods; 2006; 53(1):1-10. PubMed ID: 16399550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo measurement of QT prolongation, dispersion and arrhythmogenesis: application to the preclinical cardiovascular safety pharmacology of a new chemical entity.
    De Clerck F; Van de Water A; D'Aubioul J; Lu HR; van Rossem K; Hermans A; Van Ammel K
    Fundam Clin Pharmacol; 2002 Apr; 16(2):125-40. PubMed ID: 12031065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of repolarization reserve by halothane anaesthesia sensitizes the guinea-pig heart for drug-induced QT interval prolongation.
    Takahara A; Sugiyama A; Hashimoto K
    Br J Pharmacol; 2005 Oct; 146(4):561-7. PubMed ID: 16056235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accurate detection of drug-induced delayed ventricular repolarization with a suitable correction formula in Langendorff guinea pig heart.
    Tabo M; Komatsu R; Isobe T; Honda M; Yamada Y; Kimura K
    J Toxicol Sci; 2010 Oct; 35(5):687-98. PubMed ID: 20930463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistical analysis of QT interval as a function of changes in RR interval in the conscious dog.
    Raunig D; Depasquale MJ; Huang CH; Winslow R; Fossa AA
    J Pharmacol Toxicol Methods; 2001; 46(1):1-11. PubMed ID: 12164254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QT prolongation in guinea pigs for preliminary screening of torsadogenicity of drugs and drug-candidates. II.
    Testai L; Breschi MC; Martinotti E; Calderone V
    J Appl Toxicol; 2007; 27(3):270-5. PubMed ID: 17265420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.